The University of Chicago Header Logo
Last Name


Search Results to Jagoda Jasielec

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following items that are connected to Jasielec, Jagoda

Item TypeName
Concept Multiple Myeloma
Academic Article Evolving strategies in the initial treatment of multiple myeloma.
Academic Article Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma.
Academic Article Proteomic profiling of naïve multiple myeloma patient plasma cells identifies pathways associated with favourable response to bortezomib-based treatment regimens.
Academic Article Synergistic Myeloma Cell Death via Novel Intracellular Activation of Caspase-10-Dependent Apoptosis by Carfilzomib and Selinexor.
Academic Article Current approaches to the initial treatment of symptomatic multiple myeloma.
Academic Article Phase 1 study of selinexor plus carfilzomib and dexamethasone for the treatment of relapsed/refractory multiple myeloma.
Academic Article Selinexor-based regimens for the treatment of myeloma refractory to chimeric antigen receptor T cell therapy.
Academic Article Clinician attitudes and practices toward measurable residual disease in multiple myeloma.
Academic Article Impact of an Oncology Clinical Pharmacist Specialist in an Outpatient Multiple Myeloma Clinic.
Academic Article Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma.
Academic Article Racial differences in treatment and outcomes in multiple myeloma: a multiple myeloma research foundation analysis.
Academic Article Recommendations and outcomes from a geriatric assessment guided multidisciplinary clinic prior to autologous stem cell transplant in older patients.
Academic Article Measurable residual disease assessed by mass spectrometry in peripheral blood in multiple myeloma in a phase II trial of carfilzomib, lenalidomide, dexamethasone and autologous stem cell transplantation.
Academic Article Efficacy and safety of carfilzomib-lenalidomide-dexamethasone in newly diagnosed multiple myeloma: pooled analysis of four single-arm studies.
Academic Article Elotuzumab and Weekly Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Without Transplant Intent: A Phase 2 Measurable Residual Disease-Adapted Study.

Search Criteria
  • Multiple Myeloma